Literature DB >> 16428437

E2A and IRF-4/Pip promote chromatin modification and transcription of the immunoglobulin kappa locus in pre-B cells.

Adam S Lazorchak1, Mark S Schlissel, Yuan Zhuang.   

Abstract

The immunoglobulin kappa light chain (Igkappa) locus is regulated in a lineage- and stage-specific manner during B-cell development. The highly restricted timing of V to J gene recombination at the pre-B-cell stage is under the control of two enhancers, the intronic enhancer (kappaEi) and the 3' enhancer (kappaE3'), flanking the constant exon. E2A transcription factors have been indicated to be directly involved in the regulation of Igkappa locus activation. In this study, we utilize E2A-deficient pre-B cells to directly investigate the mechanism of E2A-mediated Igkappa activation. We demonstrate that Igkappa germ line transcription is severely impaired and recombination is blocked in the absence of E2A. Reconstitution of E2A-/- pre-B cells with inducible human E2A (E47R) is sufficient to promote chromatin modification of Igkappa and rescue Igkappa germ line transcription and Jkappa gene recombinase accessibility. Furthermore, we show that increased E2A recruitment to kappaEi and kappaE3' correlates with activation of Igkappa in pre-B cells and that recruitment of E2A to kappaE3' is in part dependent on the transcription factor IRF-4. Inhibition of IRF-4 expression in pre-B cells leads to a significant reduction of Igkappa germ line transcription and enhancer acetylation. In the absence of E2A, increased IRF-4 expression is not sufficient to promote Igkappa enhancer chromatin modification or transcription, suggesting that the sequential involvement of IRF-4 and E2A is necessary for the activation of the Igkappa locus. Finally, we provide genetic evidence in the mouse that E2A gene dosage can influence the development of pre-B cells during the phase of Igkappa gene activation.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16428437      PMCID: PMC1347029          DOI: 10.1128/MCB.26.3.810-821.2006

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  37 in total

1.  PU.1 recruits a second nuclear factor to a site important for immunoglobulin kappa 3' enhancer activity.

Authors:  J M Pongubala; S Nagulapalli; M J Klemsz; S R McKercher; R A Maki; M L Atchison
Journal:  Mol Cell Biol       Date:  1992-01       Impact factor: 4.272

2.  Functional characterization of the developmentally controlled immunoglobulin kappa 3' enhancer: regulation by Id, a repressor of helix-loop-helix transcription factors.

Authors:  J M Pongubala; M L Atchison
Journal:  Mol Cell Biol       Date:  1991-02       Impact factor: 4.272

3.  A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins.

Authors:  C Murre; P S McCaw; D Baltimore
Journal:  Cell       Date:  1989-03-10       Impact factor: 41.582

4.  Transcription of the unrearranged mouse C kappa locus: sequence of the initiation region and comparison of activity with a rearranged V kappa-C kappa gene.

Authors:  B G Van Ness; M Weigert; C Coleclough; E L Mather; D E Kelley; R P Perry
Journal:  Cell       Date:  1981-12       Impact factor: 41.582

5.  Long-range interactions between three transcriptional enhancers, active Vkappa gene promoters, and a 3' boundary sequence spanning 46 kilobases.

Authors:  Zhe Liu; William T Garrard
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

6.  Deletion of the Ig kappa light chain intronic enhancer/matrix attachment region impairs but does not abolish V kappa J kappa rearrangement.

Authors:  Y Xu; L Davidson; F W Alt; D Baltimore
Journal:  Immunity       Date:  1996-04       Impact factor: 31.745

7.  The helix-loop-helix gene E2A is required for B cell formation.

Authors:  Y Zhuang; P Soriano; H Weintraub
Journal:  Cell       Date:  1994-12-02       Impact factor: 41.582

8.  The kappa/lambda ratio in surface immunoglobulin molecules on B lymphocytes differentiating from DHJH-rearranged murine pre-B cell clones in vitro.

Authors:  A Rolink; M Streb; F Melchers
Journal:  Eur J Immunol       Date:  1991-11       Impact factor: 5.532

9.  Pip, a novel IRF family member, is a lymphoid-specific, PU.1-dependent transcriptional activator.

Authors:  C F Eisenbeis; H Singh; U Storb
Journal:  Genes Dev       Date:  1995-06-01       Impact factor: 11.361

10.  E2A proteins are required for proper B cell development and initiation of immunoglobulin gene rearrangements.

Authors:  G Bain; E C Maandag; D J Izon; D Amsen; A M Kruisbeek; B C Weintraub; I Krop; M S Schlissel; A J Feeney; M van Roon
Journal:  Cell       Date:  1994-12-02       Impact factor: 41.582

View more
  32 in total

1.  Transcription factor Ebf1 regulates differentiation stage-specific signaling, proliferation, and survival of B cells.

Authors:  Ildiko Györy; Sören Boller; Robert Nechanitzky; Elizabeth Mandel; Sebastian Pott; Edison Liu; Rudolf Grosschedl
Journal:  Genes Dev       Date:  2012-03-19       Impact factor: 11.361

2.  NFAT and IRF proteins regulate transcription of the anti-HIV gene, APOBEC3G.

Authors:  Melissa A Farrow; Eun-Young Kim; Steven M Wolinsky; Ann M Sheehy
Journal:  J Biol Chem       Date:  2010-11-15       Impact factor: 5.157

3.  A developmentally controlled competitive STAT5-PU.1 DNA binding mechanism regulates activity of the Ig κ E3' enhancer.

Authors:  Suchita Hodawadekar; Kyoungsook Park; Michael A Farrar; Michael L Atchison
Journal:  J Immunol       Date:  2012-01-25       Impact factor: 5.422

4.  Extensive cooperation of immune master regulators IRF3 and NFκB in RNA Pol II recruitment and pause release in human innate antiviral transcription.

Authors:  Jonathan E Freaney; Rebecca Kim; Roli Mandhana; Curt M Horvath
Journal:  Cell Rep       Date:  2013-08-29       Impact factor: 9.423

Review 5.  E and ID proteins branch out.

Authors:  Barbara L Kee
Journal:  Nat Rev Immunol       Date:  2009-03       Impact factor: 53.106

6.  The miR-15 family reinforces the transition from proliferation to differentiation in pre-B cells.

Authors:  Silke E Lindner; Michael Lohmüller; Bianka Kotkamp; Fabian Schuler; Zeynep Knust; Andreas Villunger; Sebastian Herzog
Journal:  EMBO Rep       Date:  2017-07-13       Impact factor: 8.807

Review 7.  Effects of acute and chronic inflammation on B-cell development and differentiation.

Authors:  Derek Cain; Motonari Kondo; Huaiyong Chen; Garnett Kelsoe
Journal:  J Invest Dermatol       Date:  2009-02       Impact factor: 8.551

8.  IL-7 specifies B cell fate at the common lymphoid progenitor to pre-proB transition stage by maintaining early B cell factor expression.

Authors:  Kazu Kikuchi; Hirotake Kasai; Akiko Watanabe; Anne Y Lai; Motonari Kondo
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

9.  A role for interferon regulatory factor 4 in receptor editing.

Authors:  Simanta Pathak; Shibin Ma; Long Trinh; Runqing Lu
Journal:  Mol Cell Biol       Date:  2008-02-19       Impact factor: 4.272

10.  A tamoxifen inducible knock-in allele for investigation of E2A function.

Authors:  Mary E Jones; Motonari Kondo; Yuan Zhuang
Journal:  BMC Dev Biol       Date:  2009-10-12       Impact factor: 1.978

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.